Iodine Contrasts Effectiveness and Safety in Contrast Enhanced Mammography and breast magnetic resonance imaging.

2023-507644-37-00 Protocol DICES Therapeutic confirmatory (Phase III) Ongoing, recruiting

Start 13 Dec 2024 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol DICES

Overview

Sponsor-declared trial summary

Phase Therapeutic confirmatory (Phase III)
Status Ongoing, recruiting
Participants planned 900
Countries 1
Sites 1

Breast cancer

Key facts

Sponsor
Uniwersytet Jagiellonski Collegium Medicum
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Female
Therapeutic area
Diseases [C] - Neoplasms [C04]
Trial duration
13 Dec 2024 → ongoing
Decision date (initial)
2024-05-27
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Breast cancer

VersionLevelCodeTermSystem organ class
20.0 PT 10006187 Breast cancer 100000004864

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Uniwersytet Jagiellonski Collegium Medicum

Sponsor organisation
Uniwersytet Jagiellonski Collegium Medicum
Address
Ul. Sw. Anny 12
City
Cracow
Postcode
31-008
Country
Poland

Scientific contact point

Organisation
Uniwersytet Jagiellonski Collegium Medicum
Contact name
Elżbieta Łuczyńska

Public contact point

Organisation
Uniwersytet Jagiellonski Collegium Medicum
Contact name
Jagiellońskie Centrum Wsparcia Badań Klinicznych

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Poland Ongoing, recruiting 900 1
Rest of world 0

Investigational sites

Poland

1 site · Ongoing, recruiting
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie
Pracownia Diagnostyki Obrazowej Piersi, Ul. Macieja Jakubowskiego 2, 30-688, Krakow

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Poland 2024-12-13 2025-01-21

Application history

5 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-02-06 Poland Acceptable with conditions
2024-05-20
2024-05-27
2 SUBSTANTIAL MODIFICATION SM-1 2024-07-15 Poland Acceptable
2024-09-13
2024-09-16
3 SUBSTANTIAL MODIFICATION SM-2 2025-11-12 Poland Acceptable
2026-02-16
2026-02-22
4 NON SUBSTANTIAL MODIFICATION NSM-1 2026-02-23 Poland Acceptable
2026-02-16
2026-02-23
5 NON SUBSTANTIAL MODIFICATION NSM-2 2026-03-09 Poland Acceptable
2026-02-16
2026-03-09